Newsletter

Age-Related Macular Degeneration (AMD)
How is pharmaceutical domain dealing with Age-related macular degeneration burden?
Age-Related Macular Degeneration Market

More Whitepapers / Newsletters

Primary Progressive Aphasia Market
Primary Progressive Aphasia (P...

Primary Progressive Aphasia (PPA) is a rare neurological disorder that results from the damages to the areas of brain responsible for communication (language and speech). Affected patients experience...

Fibrodysplasia Ossificans Progressiva Newsletter
Fibrodysplasia Ossificans Prog...

Fibrodysplasia Ossificans Progressiva (FOP) is a rare disorder that results in gradual ossification of the connective tissues and muscle tissues, such as ligaments and tendons. They are replaced by bo...

Duchenne Muscular Dystrophy Newsletter
Duchenne Muscular Dystrophy

A genetic disorder, Duchenne Muscular Dystrophy (DMD), is a progressive form of muscular dystrophy with a higher preponderance in males; however, in some rare cases, it can occur in females too. As pe...

ASCO: Evolution of Precision Medicine
Let Us Hear From ASCO: Evoluti...

Past decades have witnessed a shift in the focus of researchers and pharma companies towards tailoring the treatment approach and regiment cancer patients are administered. Unlike traditional chemothe...

Impact of Brexit on Pharma Space Newsletter
Impact Of BREXIT On Pharma Spa...

The Union of the European countries, also known as the European Union or the EU, is more or less like a conglomerate of countries. These countries make up the whole continent. The economic and politic...